Growing community of inventors

Osaka, Japan

Tetsu Nakane

Average Co-Inventor Count = 7.15

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Tetsu NakaneAkira Kubo (3 patents)Tetsu NakaneRitsuo Imashiro (3 patents)Tetsu NakaneHidetaka Miyoshi (3 patents)Tetsu NakaneAkihito Ogasawara (3 patents)Tetsu NakaneTatsuo Nakajima (3 patents)Tetsu NakaneHajime Hiramatsu (2 patents)Tetsu NakaneHiroaki Sakurai (2 patents)Tetsu NakaneAtsushi Sato (1 patent)Tetsu NakaneYasuo Yamamoto (1 patent)Tetsu NakaneHidekazu Tsujishima (1 patent)Tetsu NakaneKouichi Tanimoto (1 patent)Tetsu NakaneChihiro Toshikawa (1 patent)Tetsu NakaneTakanori Murakami (1 patent)Tetsu NakaneTetsu Nakane (4 patents)Akira KuboAkira Kubo (48 patents)Ritsuo ImashiroRitsuo Imashiro (6 patents)Hidetaka MiyoshiHidetaka Miyoshi (3 patents)Akihito OgasawaraAkihito Ogasawara (3 patents)Tatsuo NakajimaTatsuo Nakajima (3 patents)Hajime HiramatsuHajime Hiramatsu (3 patents)Hiroaki SakuraiHiroaki Sakurai (2 patents)Atsushi SatoAtsushi Sato (51 patents)Yasuo YamamotoYasuo Yamamoto (17 patents)Hidekazu TsujishimaHidekazu Tsujishima (3 patents)Kouichi TanimotoKouichi Tanimoto (1 patent)Chihiro ToshikawaChihiro Toshikawa (1 patent)Takanori MurakamiTakanori Murakami (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Mitsubishi Tanabe Pharma Corporation (4 from 257 patents)


4 patents:

1. 10487072 - Substituted imidazoles as melanocortin receptor agonists

2. 7846933 - 4-imidazolin-2-one compounds

3. 7700771 - Heterocyclic compound which may be used as a medicine having p38 MAP kinase inhibitory activity

4. 7473695 - 4-imidazolin-2-one compounds

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…